Pfizer's suffering from generics, but 'innovation for growth'—not big M&A—is still the mantra - FiercePharma

  1. Pfizer's suffering from generics, but 'innovation for growth'—not big M&A—is still the mantra  FiercePharma
  2. Pfizer's earnings outlook disappoints after Viagra loses patent protection and Lyrica faces same fate  CNBC
  3. Pfizer quarterly profit in line, touts pipeline of future products  Yahoo Finance
  4. Pfizer Tops Q4 Earnings But Guides for Weaker 2019 as Lyrica Exclusivity Ends  TheStreet.com
  5. Pfizer's Outlook Disappoints as Drugmaker Focuses on Pipeline  Bloomberg
  6. View full coverage on Google News


from Top stories - Google News http://bit.ly/2G9KLRV

Comments

Post a Comment

Popular posts from this blog

U.S.-Canada 4 Nations Face-Off final draws 9.3 million viewers, most-watched NHL-sanctioned game in decades - The New York Times

U.S.-Canada 4 Nations Face-Off final draws 9.3 million viewers, most-watched NHL-sanctioned game in decades    The New York Times Justin Trudeau sends fiery message to US after Canada's 4 Nations win    Fox News Canada Just Beat the United States in Hockey. What the NHL Players Did Afterward Was Inspiring    Inc. USA-Canada 4 Nations final sets betting records    ESPN 4 Nations Face-Off final performs better than any NHL game in U.S., ever    NBC Sports from Top stories - Google News https://ift.tt/Yvtf914
Read more

Georgia hospitals test ‘game-changer’ pancreatic cancer drugs - Atlanta Journal-Constitution

Georgia hospitals test ‘game-changer’ pancreatic cancer drugs    Atlanta Journal-Constitution Breakthrough pancreatic cancer drug nearly doubles survival in trial    USA Today In Fight Against Pancreatic Cancer, Daraxonrasib Is Rare Sign Of Hope    Yahoo KRAS inhibitor therapy for pancreatic cancer    UW Homepage A New Targeted Option on the Horizon for Pancreatic Cancer – CancerWorld    Oncodaily from Top stories - Google News https://ift.tt/NTqa3RB
Read more

Before Carlos Alcaraz Was Great, He Was Good Enough to Be Lucky - The New York Times

Before Carlos Alcaraz Was Great, He Was Good Enough to Be Lucky    The New York Times After Carlos Alcaraz says doubles with Rafael Nadal would be 'a dream,' what pairs would we love to see?    Tennis Magazine French Open 2023: Carlos Alcaraz vs Flavio Cobolli preview, head-to-head, prediction, odds and pick | Roland Garros    Sportskeeda Carlos Alcaraz and Rafael Nadal in doubles at the 2024 Olympics: not a utopia!    Tennis World USA ‘This boy was born to be No 1’: the making of Carlos Alcaraz    The Guardian View Full Coverage on Google News from Top stories - Google News https://ift.tt/cOKTjvw
Read more